Advanced Kidney Cancer
5 clinical trials · Condition
◉ Watch Advanced Kidney Cancer
| Record | Firm | Date |
|---|---|---|
| Tislelizumab Plus Lenvatinib in Stage III-IV RCC (NCT05485883) | Tianjin Medical University Second Hospital | 2022-07-01 |
| Circulating and Urinary Exosomal miRNA in Advanced Kidney Cancer (EXO-RENAL1) (NCT07406646) | Institute of Oncology Ljubljana | 2021-11-02 |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer (NCT03540199) | Fuda Cancer Hospital, Guangzhou | 2018-04-10 |
| Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer (NCT03308396) | Ajjai Alva, MD | 2017-12-19 |
Track Advanced Kidney Cancer automatically
Every clearance here is in the API, with alerts when new ones post.